Azenta, Inc. - Common Stock AZTA 深 沪
等待开盘 12-17 09:30:00 美东时间
34.445
-0.635
-1.81%
华盛通- 最 高35.185
- 今 开35.03
- 成交量 25.16万股
- 最 低 34.38
- 昨 收 35.08
- 总市值 15.79亿
- 52周最高 55.635
- 市盈率 静 --
- 换手率 0.55%
- 52周最低 23.91
- 委 比 -79.04%
- 总股本 4583.97万
- 历史最高 124.69
- 量 比 0.42
- 振 幅 2.29%
- 历史最低 3.92
- 每 手 1
- 风险率 8.35%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Azenta shares are trading higher after the company approved a $250 million share repurchase program.
Azenta shares are trading higher after the company approved a $250 million shar...
12-11 02:12
Azenta Approves $250M Share Repurchase Program
Azenta, Inc. (NASDAQ:AZTA) today announced that its Board of Directors has approved a share repurchase program under which the company may repurchase up to $250 million of its outstanding common stock. The Repurchase
12-11 01:45
美股大行评级 | 安捷伦科技、Keysight、先科电子获多家大行上调目标价；摩根大通下调亿航智能评级至"中性"，目标价下调至13美元
今日重点评级关注：HC Wainwright & Co.：维持BiomX"买入"评级，目标价从15美元升至26美元；Clear Street：维持Diversified Energy"买入"评级，目标价从23美元升至25美元
11-26 10:07
Raymond James Maintains Outperform on Azenta, Raises Price Target to $45
Raymond James analyst Andrew Cooper maintains Azenta (NASDAQ:AZTA) with a Outperform and raises the price target from $35 to $45.
11-26 02:22
Azenta shares are trading lower after the company reported better-than-expected Q4 financial results.
Azenta shares are trading lower after the company reported better-than-expected...
11-21 21:54
Azenta Q4 Adj. EPS $0.21 Beats $0.19 Estimate, Sales $159.000M Beat $156.150M Estimate
Azenta (NASDAQ:AZTA) reported quarterly earnings of $0.21 per share which beat the analyst consensus estimate of $0.19 by 10.53 percent. This is a 10.53 percent increase over earnings of $0.19 per share from the same
11-21 19:31
Earnings Scheduled For November 21, 2025
Companies Reporting Before The Bell • OMS Energy Technologies (NASDAQ:OMSE) is ...
11-21 19:11
Azenta Collaborates With PRECEDE Foundation To Offer Storage Of Study Samples In Biorepository And Streamline Logistics For Diagnostics, Patient Survival
Azenta, Inc. (Nasdaq: AZTA) today announced a strategic partnership with the PRECEDE Foundation, an international, multi-institutional collaborative focused on early detection and prevention of pancreatic cancer. Azenta
11-05 05:28
美股大行评级 | 最高350美元！16家大行上调谷歌目标价！Meta遭12家大行下调目标价；潜在涨幅1456.29%！NRX Pharmaceuticals获Ascendiant Capital升目标价至47美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持NRX Pharmaceuticals"买入"评级，目标价从46美元升至47美元；富国银行：维持Kyverna Therapeutics"超配"评级，目标价从27美元升至31美元
10-31 10:25
Jefferies Upgrades Azenta to Buy, Raises Price Target to $38
Jefferies analyst Matthew Stanton upgrades Azenta (NASDAQ:AZTA) from Hold to Buy and raises the price target from $30 to $38.
10-30 20:04
